FibroGen Inc

FGEN

Get informed when a big investor buys or sells

Market Cap$36.69M

Close$

Compare to Similar Companies

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
FibroGen Inc	0.3	-	-1761%	9.1	-0.6

$-1.28

Current Fair Value

114.1% downside

Overvalued by 114.1% based on the discounted cash flow analysis.

Share Statistics

Market cap	$36.69 Million
Enterprise Value	$5.38 Million
Dividend Yield	$- (-)
Earnings per Share	$45.37
Beta	0.77
Outstanding Shares	4,047,000

Return

Return on Equity	-1761.19%
Return on Assets	149.24%
Return on Invested Capital	-56.37%

Valuation & Multiples

P/E Ratio	0.25
PEG	-0.06
Price to Sales	9.07
Price to Book Ratio	-3.02
Enterprise Value to Revenue	0.72
Enterprise Value to EBIT	-0.12
Enterprise Value to Net Income	0
Total Debt to Enterprise	1.06
Debt to Equity	-0.61

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date

November 10, 2025

EPS Estimate

$-4.01

Average shareholder expectation

Revenue Estimate

$1.67 M

Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio	0.2002▲ 0.94%
Total Calls	235,300▼ 4.70%
Total Puts	47,1000%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %	28.46%▲ 0.45%
Total Invested	$10.10M▼ 27.16%
Investors Holding	34▲ 1.00%

ESG Score